Skip to content
Their Record

House Roll Call 585, 116th Congress · October 28, 2019

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Question before the chamber: On Motion to Suspend the Rules and Pass, as Amended

403 yea · 0 nayPassed28 not voting or present
Democrat217 yea · 0 nay
Republican184 yea · 0 nay
Independent1 yea · 0 nay
Other1 yea · 0 nay

Solid = yea, faded = nay.

The measure

H.R. 2115 ↗

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareDirection unreadable — not scored

    excluded:model-unclear (0.90) Drug pricing transparency does not directly expand or restrict health care coverage.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (403)

Nay (0)

None

Not voting or present (28)

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.